期刊文献+

心力衰竭合并心房颤动:从基础科学到临床实践 被引量:1

下载PDF
导出
摘要 心力衰竭和心房颤动常因共同的危险因素和病理生理机制而共存,预后不佳。该文主要介绍心力衰竭合并心房颤动的病理生理机制、预后以及治疗策略。
作者 夏平 杨浩
出处 《国际心血管病杂志》 2016年第2期87-89,共3页 International Journal of Cardiovascular Disease
  • 相关文献

参考文献27

  • 1陈鑫,吴士尧.心力衰竭与心房颤动[J].国际心血管病杂志,2010,37(4):216-218. 被引量:5
  • 2Mamas MA, Caldwell JC, Chacko S, et al. A meta-analysis of the prognostic significance of atrial fibrillation in chronic heart failure[J]. Eur J Heart Fail, 2009,11(7) .. 676-683.
  • 3肖兴平,薛竟宜,李为民.心力衰竭合并心房颤动与心房纤维化研究[J].国际心血管病杂志,2012,39(2):68-70. 被引量:3
  • 4Cha YM, Redfield MM, Shen WK, et al. Atrial fibrillation and ventricular dysfunction: a vicious electromechanical cycle FJ~. Circulation,2004,109(23) .. 2839-2843.
  • 5Tsai CT, Lai LP, Kuo KT, et al. Angiotensin I] activates signal transducer and activators of transcription 3 via Racl in atrial myocytes and fibroblasts: implication for the therapeutic effect of statin in atrial structural remodelingEJ~. Circulation. 2008. 117(3).. 344-355. .
  • 6Rosenkranz S. TGF-betal and angiotensin networking in cardiac remodeling [J 1. Cardiovasc Res, 2004, 63 (3): 423-432.
  • 7Liao CH, Akazawa H, Tamagawa M, et al. Cardiac mast cells cause atrial fibrillation through PI~F-A-mediated fibrosis in pressure-overloaded mouse hearts I-J1. J Clin Invest,2010,120(1) : 242-253.
  • 8Qu YC, Du YM, Wu SL, et al. Activated nuclear factor- kappaB and increased tumor necrosis factor-alpha in atrial tissue of atrial fibrillation[J~. Scand Cardiovasc J, 2009, 43 (5) : 292-297.
  • 9Goette A, Lendeckel U, Klein HU. Signal transduction systems and atrial fibrillationEJ~. Cardiovasc Res, 2002, 54 (2) : 247-258.
  • 10van der Velden HM, Ausma J, Rook MB, et al. Gap junctional remodeling in relation to stabilization of atrial fibrillation in the goat[J]. Cardiovasc Res,2000,46(3) : 476-486.

二级参考文献20

  • 1周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量:1402
  • 2Nasr IA,Bouzamondo A,Hulot JS,et al.Prevention of atrial fibrillation onset by beta-blocker treatment in heart failure:a meta-analysis[J].Eur Heart J,2007,28(4):457-462.
  • 3Rich MW,Me Sherry F,Williford WO,et al.Effect of age on mortality,hospitalizations and response to digoxin in patients with heart failure:the DIG study[J].J Am Coil Cardiol,2001,38(3):806-813.
  • 4Manolis AG,Katsivas AG,Lazaris EE,et al.Ventricular performance and quality of life in patients who underwent radiofrequency AV junction ablation and permanent pacemaker implantation due to medically refractory atrial tachyarrhythmias[J].J Interv Card Electrophysiol,1998,2(1):71-76.
  • 5Hsu LF,Jais P,Sanders P,et al.Catheter ablation for atrial fibrillation in congestive heart failure[J].N Engl J Med,2004.351(23):2373-2383.
  • 6Amit G,Qin H,Donahue JK.Biological therapies for atrial fibrillation[J].J Cardiovasc Pharmacol,2008,52(3):222-227.
  • 7Koelling TM,Chen RS,Lubwama RN,et al.The expanding national burden of heart failure in the United States:the influence of heart failure in women[J].Am Heart J,2004,147(1):74-78.
  • 8Everett TH 4th,Olgin JE.Atrial fibrosis and the mechanisms of atrial fibrillation[J].Heart Rhythm,2007,4(3 Suppl):S24-S27.
  • 9Maisel WH,Stevenson LW.Atrial fibrillation in the heart failure:epidemiology,pathophysiology and rationale for therapy[J].Am J Cardiol.20113,91(bA):2D-8D.
  • 10Pitt B,Zannad F,Remme WJ,et al.The effect of spironolactone on morbidity and mortality in patients with severe heart failure[J].N Engl J Med,1999,341(10):709-717.

共引文献6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部